Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Taeyang Corporation (053620:KRX), powered by AI.
Taeyang Corporation is currently trading at ₩6,800. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Taeyang Corporation on Alpha Lenz.
Taeyang Corporation's P/E ratio is 4.9.
“Taeyang Corporation trades at a P/E of 4.9 (undervalued) with modest ROE of 6.3%.”
Ask for details →Taeyang Corporation is a key player in the cosmetics and personal care product manufacturing industry. The company's primary function is to develop, produce, and distribute a wide array of beauty and skincare products that cater to diverse consumer needs. Known for its commitment to quality and innovation, Taeyang Corporation leverages state-of-the-art technology and research to deliver advanced formulations and sustainable packaging solutions. The corporation impacts various sectors, including retail and healthcare, by offering products that span from basic skincare items to specialized treatments and luxury cosmetic lines. With its roots firmly planted in South Korea, Taeyang Corporation plays a significant role in the global cosmetic market. It positions itself both as an industry leader within the competitive Asian markets and as a contributor to the expanding demand for skincare products worldwide. Through strategic partnerships and an extensive distribution network, Taeyang Corporation continues to respond to changing consumer preferences and industry trends, thereby maintaining its relevance and influence in the fast-evolving beauty sector.
“Taeyang Corporation trades at a P/E of 4.9 (undervalued) with modest ROE of 6.3%.”
Ask for details →Taeyang Corporation (ticker: 053620) is a company listed on KRX in the Basic Materials sector (Specialty Chemicals). It has approximately 224 employees. Market cap is $58.4B.
The current price is ₩6,800 with a P/E ratio of 4.93x and P/B of 0.3x.
ROE is 6.27% and operating margin is 1.71%. Annual revenue is $140.4B.